As of 2026-06-25, the Fair Value of Abcellera Biologics Inc (ABCL) is -2.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.03 USD, the upside of Abcellera Biologics Inc is -139.09%.
With the market price of 6.03 USD and our fair value calculation, Abcellera Biologics Inc (ABCL) is not a good investment. Investing in ABCL stocks now will result in a potential loss of 139.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 153.50 | 158.50 | -146.40 | -162.86 | -146.41 | -28.73 |
| YoY growth | 29.10% | 3.26% | -192.36% | -11.24% | 10.10% | -32.23% |
| Market Cap (mil) | 1,841.44 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | -32.23% |
| TTM earnings | -143.96 |